CALABRESE, Cecilia
 Distribuzione geografica
Continente #
EU - Europa 37
NA - Nord America 4
SA - Sud America 4
AS - Asia 3
Totale 48
Nazione #
IT - Italia 30
BR - Brasile 4
US - Stati Uniti d'America 4
IE - Irlanda 3
DE - Germania 2
JP - Giappone 2
FR - Francia 1
RS - Serbia 1
VN - Vietnam 1
Totale 48
Città #
Marano Di Napoli 16
Naples 4
Como 3
Dublin 3
Tokyo 2
Torre del Greco 2
Bremen 1
Caserta 1
Dong Ket 1
Foz Do Iguaçu 1
Houston 1
Novi Sad 1
Paris 1
Totale 37
Nome #
Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans, file dfd1c04b-3b94-0799-e053-6605fe0a8ddb 13
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers., file 4e876764-ddc0-49ad-b4cd-80dc062a2fd7 4
NMR metabolomic analysis of exhaled breath condensate of asthmatic patients at two different temperatures, file dfd1c04c-462e-0799-e053-6605fe0a8ddb 4
Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma, file dfd1c04c-4387-0799-e053-6605fe0a8ddb 3
Clinical impact of nasal budesonide treatment on COPD patients with coexistent rhinitis, file dfd1c04c-4434-0799-e053-6605fe0a8ddb 3
Application of proteomics and peptidomics to COPD., file dfd1c04c-4edb-0799-e053-6605fe0a8ddb 3
Negative-Pressure Ventilation in Neuromuscular Diseases in the Acute Setting, file 4f7bd3e1-5dca-4d7a-8392-336a640e3614 2
NMR spectroscopy metabolomic profiling of exhaled breath condensate in patients with stable and unstable cystic fibrosis, file dfd1c04a-4872-0799-e053-6605fe0a8ddb 2
Randomized, single blind, controlled trial of inhaled glutathione vs placebo in patients with cystic fibrosis, file dfd1c04b-3f1f-0799-e053-6605fe0a8ddb 2
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus, file 0ca1df64-3e5d-461a-b970-bf63b61e64bc 1
Patient and physician perspectives on biological treatment in severe asthma: a Severe Asthma Network Italy survey, file 5b53714f-3b79-452e-8b66-d66dcc8846bc 1
Novel Biological Therapies for Severe Asthma Endotypes, file bae07f9c-37a1-462e-aac9-499e7b30976f 1
Imbalance of circulating dendritic cell subsets in chronic obstructive pulmonary disease., file dfd1c04a-2364-0799-e053-6605fe0a8ddb 1
Lung mast cells are a source of secreted phospholipases A(2)., file dfd1c04a-2422-0799-e053-6605fe0a8ddb 1
Upregulation of miR-21 by Ras in vivo and its role in tumor growth, file dfd1c04a-333b-0799-e053-6605fe0a8ddb 1
T cell activation state in the induced sputum of asthmatics treated with budesonide, file dfd1c04a-4f7e-0799-e053-6605fe0a8ddb 1
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages, file dfd1c04a-59ec-0799-e053-6605fe0a8ddb 1
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma, file dfd1c04b-4e24-0799-e053-6605fe0a8ddb 1
H-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLC., file dfd1c04c-462b-0799-e053-6605fe0a8ddb 1
Evidence of angiogenesis in bronchial biopsies of smokers with and without airway obstruction, file dfd1c04c-4983-0799-e053-6605fe0a8ddb 1
Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness, file dfd1c04c-4c75-0799-e053-6605fe0a8ddb 1
Association between exhaled nitric oxide and nasal polyposis in severe asthma, file dfd1c04d-3e30-0799-e053-6605fe0a8ddb 1
Three Month Follow-Up of Patients With COVID-19 Pneumonia Complicated by Pulmonary Embolism, file ecbafad1-c064-455f-a7b5-a102acb3fc0f 1
Totale 50
Categoria #
all - tutte 331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 4 0
2020/20215 3 0 0 0 0 0 0 1 0 0 0 1
2021/20224 0 0 0 0 0 0 0 0 0 0 2 2
2022/202312 0 0 2 2 1 3 0 0 4 0 0 0
2023/20242 0 0 0 0 0 0 2 0 0 0 0 0
Totale 50